2-Hydroxy-5-oxo-Rivaroxaban | 1160169-96-9

• 分子结构分类: 有机化合物 - 有机杂环化合物
• 英文名称: 2-Hydroxy-5-oxo-Rivaroxaban
• 英文别名: 5-chloro-N-[[(5S)-3-[4-(2-hydroxy-5-oxomorpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]thiophene-2-carboxamide
• CAS: 1160169-96-9
• 化学式: C₁₉H₁₈ClN₃O₆S
• 分子量: 451.9
• InChiKey: UBDKZHPDNBKQFQ-CWQZNGJJSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  30
• 可旋转键数：
  5
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.32
• 拓扑面积：
  137
• 氢给体数：
  2
• 氢受体数：
  7

文献信息

• METHODS AND APPARATUS FOR A WEARABLE ELECTRONIC DIGITAL THERAPEUTIC DEVICE
  申请人：Daniels John J.

  公开号：US20210244941A1

  公开（公告）日：2021-08-12

  A wearable electronic therapeutic device has one or more biometric detectors each for detecting one or more biometric parameters. The biometric parameters are dependent on at least one physiological change to a patient in response to a therapeutic treatment. A microprocessor receives the one or more biometric parameters and applies probabilistic analysis to determine if at least one physiological change threshold has been exceeded dependent on the probabilistic analysis of the two or more biometric parameters. An activation circuit activates an action depending on the determined exceeded physiological change. The action that is activated can be applying an elcetroceutical treatment in addition or as an alternative to a pharmaceutical treatment.